Literature DB >> 16153995

Evidence that new antihypertensives are superior to older drugs.

Jan A Staessen1, Willem H Birkenhäger.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16153995     DOI: 10.1016/S0140-6736(05)67147-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  ASCOT: a tale of two treatment regimens: is ASCOT-BPLA being hyped-up?

Authors:  Peter D Burrill
Journal:  BMJ       Date:  2005-10-29

2.  The ASCOT blood pressure lowering trial.

Authors:  Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

3.  ASCOT--old or new drugs for blood pressure?

Authors:  James Ritter; John Warren
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

4.  Association of Hemoglobin and Blood Pressure in a Chinese Community-Dwelling Population.

Authors:  Yan Xuan; Junli Zuo; Shuping Zheng; Jinbao Ji; Yi Qian
Journal:  Pulse (Basel)       Date:  2018-11-28

Review 5.  Using fixed-dose combination therapies to achieve blood pressure goals.

Authors:  Steven G Chrysant
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

6.  Perindopril: the evidence of its therapeutic impact in hypertension.

Authors:  Andrew Thomson; Mary Greenacre
Journal:  Core Evid       Date:  2007-03-31

7.  Could NICE guidance on the choice of blood pressure lowering drugs be simplified?

Authors:  Reecha Sofat; Juan P Casas; Anthony M Grosso; Brian N C Prichard; Liam Smeeth; Raymond MacAllister; Aroon D Hingorani
Journal:  BMJ       Date:  2012-01-13

8.  Interaction of body mass index and hemoglobin concentration on blood pressure among pregnant women in Guangxi, China.

Authors:  Qiuan Zhong; Jiangyan Xu; Yingquan Long; Yingying Deng; Jinlan Hu; Xiaofei Li; Xiaoqiang Qiu
Journal:  BMC Public Health       Date:  2014-05-20       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.